ERBB2 and breast carcinoma: TNBC is a clinically unique, aggressive, and highly heterogeneous subtype of breast cancer that does not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor-2 (Her2), and for which no targeted therapy exists.